Status:
RECRUITING
MIBREAST Making in Immediate Breast REconstruction And the Measurement of the EffectS of RadioTherapy
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Patients who require a removal of a breast (mastectomy) for breast cancer or future risk reduction often have immediate breast reconstruction (IBR). This can be performed using either an implant or th...
Detailed Description
Approximately 40% of all women diagnosed with breast cancer (BC) will require a mastectomy and a large proportion (60%) of these will choose to have an immediate breast reconstruction (IBR). Patient ...
Eligibility Criteria
Inclusion
- Female
- Aged \> 18
- Undergoing immediate breast reconstruction (autologous or implant based) follow mastectomy for breast cancer or as a risk-reducing strategy
- Available to attend 3D-SI appointments at specified intervals
Exclusion
- Lack of capacity
- Language barrier that prevents patients from understanding the English questionnaires
- Visual impairment
- Unable to answer study questionnaires
- Disability that may prevent appropriate positioning during the imaging process
- Unable to attend for photography
- Requiring delayed reconstruction or no longer considering a reconstruction
Key Trial Info
Start Date :
September 12 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2030
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07136753
Start Date
September 12 2024
End Date
September 1 2030
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden NHS Foundation Trust
London, United Kingdom